BRIEF-Myriad Genetics up 3.3 percent in extended trade

NEW YORK Tue May 7, 2013 5:08pm EDT

NEW YORK May 7 (Reuters) - Myriad Genetics Inc : * Up 3.3 percent to $29.23 in extended trade after Q3 results, outlook

FILED UNDER: